156 related articles for article (PubMed ID: 10963239)
1. Therapeutic implications of non-genomic glucocorticoid activity.
Lipworth BJ
Lancet; 2000 Jul; 356(9224):87-9. PubMed ID: 10963239
[No Abstract] [Full Text] [Related]
2. [Nongenomic effects of glucocorticoids].
Grzanka A; Jarzab J
Pneumonol Alergol Pol; 2009; 77(4):387-93. PubMed ID: 19722144
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists.
Stahn C; Löwenberg M; Hommes DW; Buttgereit F
Mol Cell Endocrinol; 2007 Sep; 275(1-2):71-8. PubMed ID: 17630118
[TBL] [Abstract][Full Text] [Related]
4. The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus.
Goulding NJ
Curr Opin Pharmacol; 2004 Dec; 4(6):629-36. PubMed ID: 15525555
[TBL] [Abstract][Full Text] [Related]
5. [3/3 Steroidal or glucocorticoid anti-inflammatories].
Grangeasse L; Limat S; Woronoff-Lemsi MC
Soins; 2007 Apr; (714):59-61. PubMed ID: 17533931
[No Abstract] [Full Text] [Related]
6. Molecular mechanisms of glucocorticoid action: what is important?
Newton R
Thorax; 2000 Jul; 55(7):603-13. PubMed ID: 10856322
[No Abstract] [Full Text] [Related]
7. [Molecular basis of the action of topical glucocorticoids].
Kibler-Nockowska M
Przegl Dermatol; 1979; 66(4):421-5. PubMed ID: 386434
[No Abstract] [Full Text] [Related]
8. Molecular actions of glucocorticoids: an introduction.
Baraniuk JN
J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 2):141-2. PubMed ID: 8568144
[No Abstract] [Full Text] [Related]
9. [What happens in the body with glucocorticoids? Pharmacokinetics and pharmacodynamics].
Högger P
Pharm Unserer Zeit; 2003; 32(4):296-301. PubMed ID: 12899066
[No Abstract] [Full Text] [Related]
10. [Molecular mechanism of glucocorticoid action].
Tanaka H
Ryumachi; 2002 Feb; 42(1):13-22. PubMed ID: 11925903
[No Abstract] [Full Text] [Related]
11. Animal studies with topical steroids.
Weidmann H
Acta Derm Venereol Suppl (Stockh); 1973; 53():25-7. PubMed ID: 4518659
[No Abstract] [Full Text] [Related]
12. Impact of structural modifications on the hydrocortisone molecule.
Nathansohn G; Winters G
Adv Exp Med Biol; 1984; 171():1-8. PubMed ID: 6372389
[No Abstract] [Full Text] [Related]
13. Dissociated glucocorticoid receptor ligands.
Schäcke H; Rehwinkel H
Curr Opin Investig Drugs; 2004 May; 5(5):524-8. PubMed ID: 15202726
[TBL] [Abstract][Full Text] [Related]
14. Genomic and nongenomic effects of glucocorticoids.
Stahn C; Buttgereit F
Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the development of novel glucocorticoid receptor modulators.
Berlin M
Expert Opin Ther Pat; 2010 Jul; 20(7):855-73. PubMed ID: 20553093
[TBL] [Abstract][Full Text] [Related]
16. Update on topical glucocorticoid use in children.
Morley KW; Dinulos JG
Curr Opin Pediatr; 2012 Feb; 24(1):121-8. PubMed ID: 22227781
[TBL] [Abstract][Full Text] [Related]
17. Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases.
Kato M; Hagiwara Y; Oda T; Imamura-Takai M; Aono H; Nakamura M
J Ocul Pharmacol Ther; 2011 Aug; 27(4):353-60. PubMed ID: 21574866
[TBL] [Abstract][Full Text] [Related]
18. Enhanced steroid response of a human glucocorticoid receptor splice variant.
Baker AC; Green TL; Chew VW; Tung K; Amini A; Lim D; Cho K; Greenhalgh DG
Shock; 2012 Jul; 38(1):11-7. PubMed ID: 22706020
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids.
Didonato JA; Saatcioglu F; Karin M
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 2):S11-5. PubMed ID: 8756781
[No Abstract] [Full Text] [Related]
20. Interactions between corticosteroids and beta-adrenergic agonists in asthma disease induction, progression, and exacerbation.
Anderson GP
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 2):S188-96. PubMed ID: 10712373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
